Apogee Therapeutics, Inc. (APGE) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -55.57M | -62.69M | -54.26M | -62.03M | -48.48M | -67.71M | -42.52M | -29.3M | -31.64M | -29.75M | -19.88M | -14.57M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -14.63% | 7.42% | -27.59% | -111.7% | -53.23% | -127.58% | -113.9% | -101.1% | -199.67% | -223.8% | - | - |
| Net Income | -74.11M | -69.39M | -65.02M | -66.1M | -55.34M | -67.22M | -49.02M | -33.82M | -32.09M | -31.73M | -20.84M | -18.89M |
| Depreciation & Amortization | 408K | 406K | 406K | 399K | 207K | 76K | 48K | 36K | 29K | 0 | 0 | 0 |
| Stock-Based Compensation | 17.16M | 11.93M | 11.88M | 11.34M | 11.13M | 7.61M | 5.84M | 5.7M | 4.19M | 2.21M | 1.5M | 1.11M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -569K | -783K | -680K | -839K | -1.52M | -2.23M | -3.12M | -2.76M | -2.44M | -2.75M | -232K | 0 |
| Working Capital Changes | 1.55M | -4.86M | -837K | -6.84M | -2.95M | -5.96M | 3.73M | 1.54M | -1.31M | 2.52M | -313K | 3.2M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 16K | 845K | -5.3M | 3.23M | 1.37M | -1.15M | -3.31M | 1.23M | 2.16M | 1.04M | -9.76M | 0 |
| Cash from Investing | -35.35M | -288.63M | 17.95M | 78.13M | 12.98M | 46.37M | -146.38M | -148.71M | -51.74M | -273.91M | -234.22M | 0 |
| Capital Expenditures | 0 | -62K | 0 | -768K | -4.32M | 1K | -751K | -51K | -351K | -167K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -234.22M | 0 | 0 |
| Cash from Financing | 411.17M | 374.95M | 19.74M | 1.18M | 622K | 44.36M | 383K | -150K | 450.52M | -213K | 317.3M | -1.69M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 411.17M | 374.95M | 19.74M | 1.18M | 622K | 44.36M | 383K | -150K | 450.5M | -213K | 315.6M | -1.69M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24K | 0 | 1.69M | 0 |
| Net Change in Cash | 320.25M | 23.64M | -16.57M | 17.28M | -34.87M | 23.01M | -188.52M | -178.16M | 367.14M | -69.95M | 63.2M | -16.26M |
| Free Cash Flow | -55.57M | -62.75M | -54.26M | -62.8M | -52.79M | -67.71M | -43.27M | -29.35M | -31.99M | -29.92M | -19.88M | -14.57M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -5.26% | 7.33% | -25.37% | -113.95% | -65.05% | -126.31% | -117.68% | -101.45% | -202.99% | -225.62% | - | - |
| FCF per Share | -0.80 | -1.03 | -0.92 | -1.07 | -0.91 | -1.23 | -0.76 | -0.52 | -0.64 | -0.59 | -0.39 | -0.29 |
| FCF Conversion (FCF/Net Income) | 0.75x | 0.90x | 0.83x | 0.94x | 0.88x | 1.01x | 0.87x | 0.87x | 0.99x | 0.94x | 0.95x | 0.77x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |